Penserra Capital Management LLC Ani Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$32.97 - $56.85 $9,561 - $16,486	-290 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$31.86 - $38.6 $318 - $386	10 Added 3.57%	290 $10,000
Q1 2021 May 13, 2021	SELL	$28.4 - $36.14 $142 - $180	-5 Reduced 1.75%	280 $10,000
Q4 2020 Feb 12, 2021	BUY	$23.69 - $31.47 $4,287 - $5,696	181 Added 174.04%	285 $8,000
Q3 2020 Nov 13, 2020	BUY	$26.38 - $33.1 $2,743 - $3,442	104 New	104 $2,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.